APA (7th ed.) Citation

S, E., C, P., JA, D., C, G., MA, B., P, B., . . . CE, G. (2023). Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): A Feasibility Trial of Nicotine Vaping Products for Smoking Cessation Among People Living with HIV. AIDS and behavior, 27(2), 618. https://doi.org/10.1007/s10461-022-03797-0

Chicago Style (17th ed.) Citation

S, Edwards, Puljević C, Dean JA, Gilks C, Boyd MA, Baker P, Watts P, Howard C, and Gartner CE. "Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): A Feasibility Trial of Nicotine Vaping Products for Smoking Cessation Among People Living with HIV." AIDS and Behavior 27, no. 2 (2023): 618. https://doi.org/10.1007/s10461-022-03797-0.

MLA (9th ed.) Citation

S, Edwards, et al. "Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): A Feasibility Trial of Nicotine Vaping Products for Smoking Cessation Among People Living with HIV." AIDS and Behavior, vol. 27, no. 2, 2023, p. 618, https://doi.org/10.1007/s10461-022-03797-0.